Multimodal treatment and imaging of primary pulmonary artery sarcoma: a case report.

Wenpeng Huang, Yuhan Zhou, Ge Gao, Qi Yang, Zhao Chen, Yongkang Qiu, Lele Song, Lei Kang

Open access · greenAbstract readCase Reports

In one paragraph

Article in American journal of nuclear medicine and molecular imaging, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact, top 79% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

Pulmonary Artery Sarcoma Study: A Multi-Centre European Society of Thoracic Surgeons Working Group Evaluating Diagnosis, Treatment, and Outcomes.European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery · 2026
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Wenpeng HuangDepartment of Nuclear Medicine, Peking University First Hospital Beijing 100034, PR China.

Yuhan ZhouDepartment of Radiology, The First Affiliated Hospital of Zhengzhou University Zhengzhou 450052, Henan Province, PR China.

Ge GaoDepartment of Medical Imaging, Peking University First Hospital Beijing 100034, PR China.

Qi YangDepartment of Nuclear Medicine, Peking University First Hospital Beijing 100034, PR China.

Zhao ChenDepartment of Nuclear Medicine, Peking University First Hospital Beijing 100034, PR China.

Yongkang QiuDepartment of Nuclear Medicine, Peking University First Hospital Beijing 100034, PR China.

Lele SongDepartment of Nuclear Medicine, Peking University First Hospital Beijing 100034, PR China.

Lei KangDepartment of Nuclear Medicine, Peking University First Hospital Beijing 100034, PR China.

Peking University · CNFirst Affiliated Hospital of Zhengzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary pulmonary artery sarcoma (PAS) is a malignant neoplasm of the pulmonary vascular system originating from the intima, with clinical and imaging manifestations similar to those of pulmonary thromboembolism (PTE), and is often misdiagnosed. Spectral CT and PET/CT can clearly show the extent and metastasis of PAS and are valuable in visualizing adjacent structures such as lungs, bronchi, and mediastinum, providing a strong imaging basis for the diagnosis and differentiation of PAS, allowing treatment monitoring and follow-up.

Indexed as

18F-FDGI-125 seedsPET/CTPulmonary artery sarcomaX-ray computed tomography

Identifiers

PMID36072764

PMCPMC9441926

OpenAlexW4294992046

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.